These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 16709580

  • 1. Schooling mediates brain reserve in Alzheimer's disease: findings of fluoro-deoxy-glucose-positron emission tomography.
    Perneczky R, Drzezga A, Diehl-Schmid J, Schmid G, Wohlschläger A, Kars S, Grimmer T, Wagenpfeil S, Monsch A, Kurz A.
    J Neurol Neurosurg Psychiatry; 2006 Sep; 77(9):1060-3. PubMed ID: 16709580
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis.
    Alexander GE, Furey ML, Grady CL, Pietrini P, Brady DR, Mentis MJ, Schapiro MB.
    Am J Psychiatry; 1997 Feb; 154(2):165-72. PubMed ID: 9016263
    [Abstract] [Full Text] [Related]

  • 5. Brain reserve capacity in frontotemporal dementia: a voxel-based 18F-FDG PET study.
    Perneczky R, Diehl-Schmid J, Drzezga A, Kurz A.
    Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):1082-7. PubMed ID: 17219132
    [Abstract] [Full Text] [Related]

  • 6. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM.
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D, Schuff N, Jagust W, Weiner MW, Alzheimer''s Disease Neuroimaging Initiative.
    Neurodegener Dis; 2016 May; 16(1-2):87-94. PubMed ID: 26560336
    [Abstract] [Full Text] [Related]

  • 9. Non-fluent progressive aphasia: cerebral metabolic patterns and brain reserve.
    Perneczky R, Diehl-Schmid J, Pohl C, Drzezga A, Kurz A.
    Brain Res; 2007 Feb 16; 1133(1):178-85. PubMed ID: 17184752
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Resting state glucose utilization and the CERAD cognitive battery in patients with Alzheimer's disease.
    Teipel SJ, Willoch F, Ishii K, Bürger K, Drzezga A, Engel R, Bartenstein P, Möller HJ, Schwaiger M, Hampel H.
    Neurobiol Aging; 2006 May 16; 27(5):681-90. PubMed ID: 15908048
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Measurement of regional cerebral metabolism rate of glucose in patients with Alzheimer's disease in different levels of severity].
    Xiao SF, Cao QY, Xue HB, Liu YC, Zuo CT, Jiang KD, Zhang MY.
    Zhonghua Yi Xue Za Zhi; 2005 Nov 09; 85(42):2975-9. PubMed ID: 16324383
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease.
    Haense C, Buerger K, Kalbe E, Drzezga A, Teipel SJ, Markiewicz P, Herholz K, Heiss WD, Hampel H.
    Eur J Neurol; 2008 Nov 09; 15(11):1155-62. PubMed ID: 18803648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.